<p>A comprehensive overview of transthyretin amyloidosis, its treatment, barriers to treatment, and future challenges to be aware of with authors, Drs. Erika L. Hellenbart and Robert J. DiDomenico. Full text of the manuscript is available at: <a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.4639" target="_blank" rel="ugc noopener noreferrer">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.4639</a>. </p>

A comprehensive overview of transthyretin amyloidosis, its treatment, barriers to treatment, and future challenges to be aware of with authors, Drs. Erika L. Hellenbart and Robert J. DiDomenico. Full text of the manuscript is available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.4639.

<p>A comprehensive overview of transthyretin amyloidosis, its treatment, barriers to treatment, and future challenges to be aware of with authors, Drs. Erika L. Hellenbart and Robert J. DiDomenico. Full text of the manuscript is available at: <a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.4639" rel="noopener noreferrer">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.4639</a>. </p>

Disease modifying therapies for ATTR-CM - Ep 154

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice.
ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Medicine

Health & Fitness

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice. ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Share Disease modifying therapies for ATTR-CM - Ep 154

Sign up to save your podcasts

Disease modifying therapies for ATTR-CM - Ep 154

Disease modifying therapies for ATTR-CM - Ep 154

More shows like ACCP JOURNALS

EMCrit FOAM Feed

Gastropod

The Daily

Today, Explained